Abstract
Tumor response to 6.3 MeV fast neutrons generated by U-120 cyclotron was assessed. The study included: 26 patients with locally advanced breast cancer, who received neutron therapy in the regimen of high-dose daily fractions, followed by surgery; 41patients with head and neck cancer and 44 patients with musculoskeletal system cancer. The devised method of 6.3 MeV neutron therapy given in high-dose fractionation regimen resulted in complete tumor response compared to the standard photon therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
